Mosaic ImmunoEngineering (CPMV, $0.29) was a top loser over the last three months, falling -6 to $0.29 per share. A.I.dvisor analyzed 832 stocks in the Biotechnology Industry for the 3-month period ending June 3, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.